Denali Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Denali Advisors's BIIB Position: Q2 2024 in Review
Denali Advisors sold out of Biogen (BIIB) in Q2 2024, closing a stake of 400 shares — an estimated $86.3K sold.
Denali Advisors first reported a position in BIIB in Q4 2017 and held it in 18 quarters. The position peaked at $5.13M in Q3 2020. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.
- Denali Advisors reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
- Denali Advisors sold 400 Biogen shares in Q2 2024, an estimated $86.3K.
- Denali Advisors first reported a position in Biogen in Q4 2017 and held it in 18 quarters.
- Denali Advisors's Biogen position peaked at $5.13M in Q3 2020.
- 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.
Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.